MicroRNA 200a as a histologically independent marker for meningioma recurrence: Results of a four microRNA panel analysis in meningiomas.

Steffi UrbschatBenjamin LandauNina-Christin BewersdorfCeline SchusterGudrun WagenpfeilWalter J Schulz-SchaefferJoachim OertelRalf Ketter

Published in: Cancer medicine (2022)

We detected microRNA 200a as a new biomarker to indicate meningioma recurrences. Future transferability to blood could be important for patient follow-up.

Keyphrases

case report
current status
optical coherence tomography